Suppr超能文献

地塞米松/促肾上腺皮质激素释放激素联合试验在急性发作期及缓解期躁狂患者、急性抑郁患者和正常对照中的应用:I

Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.

作者信息

Schmider J, Lammers C H, Gotthardt U, Dettling M, Holsboer F, Heuser I J

机构信息

Max Planck Institute of Psychiatry, Munich, Germany.

出版信息

Biol Psychiatry. 1995 Dec 15;38(12):797-802. doi: 10.1016/0006-3223(95)00064-X.

Abstract

Hypothalamic-pituitary-adrenal system (HPA)-function in patients with mania (n = 11), depression (n = 11, unipolar) and in control subjects (n = 11) was studied; six of the acutely manic patients were reevaluated after a symptom-free interval of at least 6 months. The combined dexamethasone-suppression/human CRH-challenge test was used to probe HPA-system function. After CRH and dexamethasone pretreatment, ACTH and cortisol release were significantly increased in both manic and depressed patients in comparison to the control group. In the remitted patients with mania, a significant decrease in hormonal release after DEX and CRH was evident when compared to the acute manic episode, but the degree of CRH-stimulated hormone secretion in these remitted patients was still significantly larger than in normal controls. This study demonstrates that acute and remitted manic episodes are associated with a profoundly dysregulated HPA-system activity.

摘要

对躁狂症患者(n = 11)、抑郁症患者(n = 11,单相)和对照组(n = 11)的下丘脑-垂体-肾上腺系统(HPA)功能进行了研究;其中6例急性躁狂症患者在至少6个月的无症状期后进行了重新评估。采用联合地塞米松抑制/人促肾上腺皮质激素释放激素(CRH)激发试验来探究HPA系统功能。与对照组相比,在CRH和地塞米松预处理后,躁狂症患者和抑郁症患者的促肾上腺皮质激素(ACTH)和皮质醇释放均显著增加。与急性躁狂发作期相比,缓解期躁狂症患者在给予地塞米松(DEX)和CRH后激素释放明显减少,但这些缓解期患者中CRH刺激的激素分泌程度仍显著高于正常对照组。本研究表明,急性和缓解期躁狂发作均与HPA系统活动严重失调有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验